San Diego
News Category
Pearl Data Powers Realtor.com Study Showing New Homes Save Buyers $25,000 Over 10 Years
A new Realtor.com study using Pearl SCORE data reveals that newly built homes save buyers an average of $25,335 over 10 years compared to 20-year-old ...
VERAXA Biotech's BiTAC-ADC Platform Shows Promise in Targeting Cancer Cells Selectively
VERAXA Biotech has announced new in vitro proof-of-concept data for its BiTAC-ADC platform, demonstrating selective cancer cell destruction, and is se...
Vibrant Nutraceuticals Launches Allerpause® Immune Blend, a Fast-Acting Natural Allergy Supplement
Vibrant Nutraceuticals introduces Allerpause® Immune Blend, a non-drowsy allergy and immune support supplement featuring clinically tested EZClear® qu...
Vibrant Nutraceuticals Launches Stomach Pro+®, a Clinically Researched Postbiotic Supplement for Digestive Health
Vibrant Nutraceuticals announces the launch of Stomach Pro+®, a postbiotic supplement featuring LJ88®, a heat-killed Lactobacillus johnsonii strain, t...
VERAXA Biotech Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
VERAXA Biotech AG highlights partnering opportunities for its BiTAC-ADC and BiTAC-TCE platforms, backed by new proof-of-concept data, at the upcoming ...
VERAXA Biotech Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform
VERAXA Biotech announced new in vitro proof-of-concept data showing its BiTAC-ADC platform can selectively kill breast cancer cells while sparing heal...
Utah Life Sciences Industry Showcases Growth at BIO International Convention
BioUtah and partners will host the Utah Pavilion at the BIO International Convention to highlight the state's rapidly expanding life sciences sector a...
Audit of 13 Local Businesses Finds Structured Data Gap Blocking AI Recommendations
An audit by LNL AI Agency reveals that 77% of local businesses lack structured data needed for AI platforms like ChatGPT and Perplexity to recommend t...
VERAXA Biotech Reports Proof-of-Concept Data for BiTAC-ADC Platform, Enhancing Cancer Therapy Precision
VERAXA Biotech AG announced in vitro proof-of-concept data for its BiTAC-ADC platform, demonstrating tumor-specific activation and reduced toxicity, w...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform at BIO 2026
Oncotelic Therapeutics introduces an AI-driven GMP manufacturing platform at BIO 2026, combining its PDAOAI technology with robotics to modernize phar...
Oncotelic Therapeutics Completes Key Phase 2 Objectives in AI-Powered GMP Manufacturing Platform
Oncotelic Therapeutics advanced its AI-powered GMP manufacturing platform at SAPU Bio, expanding capabilities for sterile manufacturing and creating c...
Handel's Ice Cream to Open New Location in Carmel Mountain Ranch
Handel's Ice Cream, ranked 1 ice cream in the world by National Geographic, opens its 12th San Diego-area shop in Carmel Mountain Ranch, led by a team...
San Diego Pediatric and Orthodontic Care Under One Roof at 4S Pediatric Dentistry & Orthodontics
4S Pediatric Dentistry & Orthodontics now offers both pediatric dental and orthodontic services in a single practice, simplifying care coordination fo...
Quantum Genesis AI Regains OTC Markets Compliance with Removal of Caveat Emptor Designation
Quantum Genesis AI Corp. announced the removal of the Caveat Emptor designation from its OTC Markets listing, signaling restored transparency and comp...
Oncotelic and Sapu Nano to Present Deciparticle Nanomedicine Platform at BIO International Convention 2026
Oncotelic Therapeutics and Sapu Nano will showcase their Deciparticle nanomedicine platform at BIO 2026, highlighting ultra-small formulations for wat...
SBMS Media Warns San Diego Contractors: Prepare for El Niño Now to Protect Winter Profits
SBMS Media issues a preparedness advisory for San Diego contractors, urging immediate action on project timelines, contracts, and marketing before pot...
Quantum Genesis AI Clarifies Research and IP Ownership in Enzyme Engineering
Quantum Genesis AI Corp. issues a statement to clarify that research publications linked to its field were conducted by separate entity Quantumzyme LL...
Radiant Smiles Expands Cosmetic and Restorative Dentistry Services in San Diego
Radiant Smiles, led by Dr. Raymond Wright III, has expanded its treatment menu to include a broader range of restorative and aesthetic services, inclu...
Experts Urge San Diego Homeowners to Prep Pool Decks Before Summer Heat
As summer approaches, experts warn San Diego homeowners about the dangers of worn pool deck surfaces, including heat burns and slip hazards, urging pr...
Tonix Pharmaceuticals Presents Preclinical Immuno-Oncology Data at AACR 2026, Highlighting Potential of TNX-1700 and TNX-4700
Tonix Pharmaceuticals announced new preclinical data for TNX-1700 and TNX-4700 at the AACR 2026 meeting, showing potential in reducing gastric cancer ...
One Good Story Project Launches to Counter Negative News
The One Good Story Project, founded by Rob Burns, launches to provide uplifting stories of empathy and compassion as an alternative to negative media ...
Clientele Luxury Magazine Q1 2026 Insights Reveal Shifting Strategies in High-Net-Worth Real Estate
Clientele Luxury Global Magazine's Q1 2026 issue highlights how top advisors across key U.S. luxury markets are navigating low inventory, design-drive...
Green Rain Energy Transitions from Strategy to Revenue with Operational EV Infrastructure Across U.S.
Green Rain Energy Holdings has completed installations and inspections of EV charging stations in California and New York, moving from development to ...
Heidelberg Pharma Presents Promising Preclinical Data for HDP-103 in Prostate Cancer at AACR 2026
Heidelberg Pharma will present data at AACR 2026 showing its Amanitin-based ADC HDP-103 is effective in difficult-to-treat prostate cancer models, wit...
Sigyn Therapeutics CEO Details Merger and Asset Sale Strategies in Shareholder Update
Sigyn Therapeutics CEO Jim Joyce outlines potential merger with a Nasdaq-listed company and asset sale initiatives to address financial challenges whi...
Quantum Genesis AI Corp. Responds to OTC Markets Caveat Emptor Designation, Plans Formal Review
Quantum Genesis AI Corp. addresses the Caveat Emptor designation on its stock by OTC Markets, planning a formal review starting March 13, 2026, to res...